0
Skip to Content
Spirair
SeptAlign
TurbAlign
About Spirair
News
Contact
Patients
Spirair
SeptAlign
TurbAlign
About Spirair
News
Contact
Patients
SeptAlign
TurbAlign
About Spirair
News
Contact
Patients
Rigo Magana 10/13/26 Rigo Magana 10/13/26

Spirair Introduces Next Iteration of SeptAlign, Shaped by Physician Feedback

Read More
Rigo Magana 10/8/26 Rigo Magana 10/8/26

Spirair Announces Publication of Multicenter Study Demonstrating Significant Six-Month Improvements with SeptAlign

Spirair Announces Publication of Multicenter Study Demonstrating Significant Six-Month Improvements with SeptAlign

Read More
Rigo Magana 7/21/25 Rigo Magana 7/21/25

Spirair Receives FDA Clearance for TurbAlign, a New Bioabsorbable Implant That Helps Keep Nasal Passages Open After Sinus Surgery

Read More
Rigo Magana 6/12/25 Rigo Magana 6/12/25

First Clinical Study of SeptAlign™ Implant Demonstrates Safety and Efficacy in Treating Nasal Septal Deviation While Preserving Cartilage

Read More
Rigo Magana 5/28/19 Rigo Magana 5/28/19

Spirair Receives FDA Clearance for SeptAlign, the First and Only Minimally Invasive Therapy for Mechanical Correction of Nasal Septal Deviation

Read More

2570 W. El Camino Real, Suite 310
Mountain View, CA 94040

About Spirair
Careers
News
Contact

SeptAlign
TurbAlign
Safety Information
For Patients

Products

Company

Copyright © 2026 Spirair, Inc. All rights reserved. Spirair and SeptAlign are registered trademarks, and TurbAlign is a trademark of Spirair, Inc. WEB-001-12

Patents ‍ ‍Terms of Service‍ Privacy Policy